ABO maternal-child discordance: Evidence of variable allelic expression and considerations for investigation - PubMed (original) (raw)

Case Reports

. 2021 Mar;61(3):979-985.

doi: 10.1111/trf.16263. Epub 2021 Jan 21.

Affiliations

Case Reports

ABO maternal-child discordance: Evidence of variable allelic expression and considerations for investigation

Tristan F P McKnight et al. Transfusion. 2021 Mar.

Abstract

Background: We report a case of apparent mother-child ABO group noninheritance. A Caucasian mother initially typed as group O and her infant group AB. Investigation ruled out preanalytical causes such as mislabeled samples and in vitro fertilization.

Materials and methods: Red blood cells were characterized by routine serologic testing. Genomic data were analyzed by targeted polymerase chain reaction-restriction fragment length polymorphism and Sanger sequencing. Transferase structures were modeled using PyMOL molecular visualization software.

Results: Serologic testing initially demonstrated the mother was group O, father group AB, and infant group AB. Further testing of the maternal sample with anti-A,B demonstrated weak A expression. Molecular testing revealed the maternal sample had an ABO*O.01.01 allele in trans to an A allele, ABO*AW.29 (c.311T>A, p.Ile104Asn), determined by gene sequencing. The sample from the infant carried the same ABO*AW.29 allele in trans to a B allele, ABO*B.01.

Conclusion: ABO genotyping revealed an A transferase encoded by ABO*AW.29, with apparent variable activity. Although A antigen expression is well known to be weak in newborns, it was robust on the red blood cells (RBCs) of the AB infant and undetectable with anti-A on the mother. Variable expression of weak subgroups may reflect competition or enhancement by a codominant allele, as well as glycan chain maturation on red cells. Previous examples in group AB mothers with Aweak infants suggested that the decreased expression is primarily due to glycan immaturity. To our knowledge, this is the first reported case of the ABO*AW.29 allele presenting with weak A expression in a group Aweak mother and robust A expression in a group AB infant, suggesting the in trans allele is an important factor in determining transferase activity and may override age-related effects.

Keywords: blood group genomics; hematology - red cells; immunohematology (RBC serology, blood groups).

© 2021 AABB.

PubMed Disclaimer

References

REFERENCES

    1. Westhoff CM. Blood group genotyping. Blood. 2019;133:1814-1820.
    1. Sandler SG, Flegel WA, Westhoff CM, et al. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion. 2015;55:680-689.
    1. Anstee DJ. Red cell genotyping and the future of pretransfusion testing. Blood. 2009;114:248-256.
    1. Chester MA, Olsson ML. The ABO blood group gene: a locus of considerable genetic diversity. Transfus Med Rev. 2001;15:177-200.
    1. Olsson ML, Chester MA. Evidence for a new type of O allele at the ABO locus, due to a combination of the A2 nucleotide deletion and the Ael nucleotide insertion. Vox Sang. 1996;71:113-117.

Publication types

MeSH terms

Substances

LinkOut - more resources